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Introduction
Dental patients commonly show a significantly re-
sorbed ridge and insufficient bone volume for dental 
implants or conventional prosthodontic treatments due 
to the congenital and acquired bone defects caused by 
periodontitis, osteomyelitis, oral cancer, and trauma, 
etc. Therefore, reconstructive surgery to augment the 
resorbed alveolar bone is often performed on these 
bone defects so that it improves retention and stability 
of removable denture and enables dental implant 
placement. Appropriate augmentation of the alveolar 
bone ensures a predictable result and good esthetics. 
Currently autogenous bone is the most preferred ma-
terial for this purpose. However, although highly ef-
fective, autogenous grafting has some limitations and 
problems in its application, which include inadequate 
supply and surgical morbidity, as well as donor site 
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Purpose: The carrier used as delivery agent for bone morphogenetic proteins(BMPs) should also act as a scaffold for new 
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A disc-shaped MBCP block (3 mm height and 8 mm diameter) was used as the carrier for the rhBMP-2 and ePTFE 
membrane was used to cover the rhBMP-2/MBCP block. The histologic and histometric parameters were used to evaluate the 
defects after 2- or 8-week healing period (7 animals/group/healing interval).
Results: The level of bone formation in the defects of both groups was significantly higher at 8 weeks than that at 2 weeks 
(P < 0.05). The ePTFE membrane has no additional effect compared with the rhBMP-2/MBCP block only. However, at 8 
weeks, rhBMP-2/MBCP/ePTFE group showed more even bone formation on the top of the MBCP block than the 
rhBMP-2/MBCP group.
Conclusion: These results suggest that the ePTFE membrane has no additive effect on bone formation when a MBCP block 
is used as a carrier for rhBMP-2. (J Korean Acad Periodontol 2008;38:325-334)
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pain and infection. Moreover, significant volumetric 
resorption of the graft poses clinical problems in the 
case of block grafts from endochondral donor sites1). 
Therefore, there is a need for alternative biomaterials 
to autogenous bone.
The bone morphogenetic protein(BMP) is expected to 
be a good substitute for autogenous bone. BMP is the 
most promising osteoinductive protein for bone re-
generation2). Since the discovery of BMPs3), more than 
20 BMPs have been identified. Several, including 
BMP-2, -4, -6 and -7, have been reported to have 
significant osteoinductive potential4,5). Among these, 
rhBMP-2 was found to have strong in vivo bone-in-
ducing ability5-7). However, the application of BMPs 
alone is not enough to induce bone formation because 
the protein rapidly diffuses from the site of application. 
Therefore, the use of a carrier system is essential for 
delivering and slowly releasingrhBMP-2 during the 
period of time required for bone formation8,9). 
For clinical success using rhBMPs, the carrier 
should be easy to manipulate and be made into a spe-
cific shape. It also needs to provide sufficient firmness 
against soft tissue pressure during the healing period. 
Our previous studies searched for excellent rhBMP 
carriers, such as an absorbable collagen sponge(ACS)9,10), 
ß-tricalcium phosphate(ß-TCP)6,9,11), a fibrin-fibronectin 
sealing system(FFSS)12,13) and a macroporous biphasic 
calcium phosphate (MBCP) block14). Each carrier material 
had its advantages and disadvantages. Although the ACS 
appeared to be an effective carrier in space-providing 
skeletal defects, it becomes victim to compressive forces 
when used for non-space-providing onlay indications. 
Osteoconductive and porous ß-TCP provided sufficient 
firmness and good biocompatibility. However, it is not 
moldable and has  limitations in providing space.
MBCP consists of an intimate mixture of hydrox-
yapatite(HA) and ß-TCP at varying HA/ß-TCP ra-
tios15), and has been reported to have favorable osteo-
conductive properties15-17). MBCP has the required po-
rous form, and can entrap rhBMP within its micro-
porous structure so that the intrinsically diffusible 
rhBMP is retained prolonging its action. Moreover, the 
porous structure of MBCP allows the infiltration of 
cells. In addition, HA in MBCP provides sufficient 
mechanical strength to resist the compressive forces 
and maintains the volume of augmented bone. It was 
reported that a MBCP block might be a suitable car-
rier for rhBMP-2 to allow predictable bone formation 
in terms of the volumetric stability14). 
The main requirement for successful bone re-
generation is the stability of the graft material in the 
defect site as well as the prevention of soft connective 
tissue ingrowth into the defect area. The use of a 
barrier membrane to cover and retain the graft mate-
rial might satisfy both prerequisites. The placement of 
a biocompatible ePTFE membrane or some other type 
of biodegradable barrier over bone defects might help 
guide bone regeneration18). However, there has been 
some controversy regarding the additional benefits of 
the membrane on bone regeneration by rhBMP19-23). 
Therefore, this study examined the osteogenic effect 
of MBCP block combined with an ePTFE membrane as 
a carrier for recombinant human bone morphogenetic 
proteins (rhBMP-2) in a rat calvarial defect model. 
The additive effect of ePTFE membrane on bone for-
mation was also evaluated. 
Materials and Methods
1. Animals
Twenty-eight male Sprague-Dawley rats (body 
weight, 200~300g) were used. They were maintained 
in plastic cages in a room with 12h-day/night cycles, 
an ambient temperature of 21ﾟC, and ad libitum access 
to water and a standard laboratory pellet diet. Animal 
selection and management, surgical protocol, and 
preparation followed the routines approved by the 
Institutional Animal Care and Use Committee, Yonsei 
Medical Center, Seoul, Korea.
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2. rhBMP-2 implant construction
The rhBMP-2(R&D Systems Inc., Minneapolis, MN, 
USA) was reconstituted and diluted in a buffer(sterile 
4 mM HCl solution containing 0.1% bovine serum al-
bumin) to produce a concentration of 0.025mg/ml. For 
the rhBMP-2/MBCP block implant, a disc-shaped MBCP 
block (3mm in height and 8mm in diameter; Biomatlante 
Inc., Vigneux de Bretagne, France) (Fig. 1) was loaded 
with 0.25ml of the rhBMP-2 solution. The rhBMP-2 
/MBCP block implants were placed in the calvarial 
defects following a 5-min binding period. 
3. Surgical procedures
The animals were generally anaesthetized by an 
intramuscular injection of ketamine hydrochloride 
(Ketalar®, Yuhan Co., Seoul, Korea) at 5mg/kg body 
weight. During surgery, routine infiltration anesthesia 
(2% lidocaine, 1:100,000 epinephrine, Kwangmyung 
Pharmaceuticals, Seoul, Korea) was used at the surgical 
site. The surgical site was shaved and scrubbed with 
iodine. An incision was made in the sagittal direction 
across the cranium and a full thickness flap was 
reflected to expose the calvarial bone. Then, a 
standardized, circular, transosseous defect, 8mm in 
diameter24), was created on the cranium using a 
saline- cooled trephine drill (3i, Palm Beach Gardens, 
FL, USA). The animals were divided into two groups 
containing 14 animals each and allowed to heal for 2 
(7 rats) or 8 weeks (7 rats). Each animal received 
one of two treatments: the rhBMP-2/MBCP block 
(rhBMP-2/MBCP group) or the rhBMP-2/ MBCP 
block/ ePTFE membrane (Gore-Tex®, W.L. Gore ＆ 
Associates Inc.) (rhBMP-2/ MBCP/ePTFE group). The 
ePTFE membrane(about 10mm in diameter) was placed 
to cover the rhBMP-2/MBCP block and no additional 
device was placed for fixation of the ePTFE membrane. 
The periosteum and skin was closed and sutured for 
primary closure with 4-0 coated sutures (Polyglactin 
910, braided absorbable suture, Ethicon, Johnson & 
Johnson Int., Edinburgh, UK).
4. Histologic and histomorphometric procedures
The animals were sacrificed by CO2 asphyxiation at 
2 and 8 weeks post-surgery. Block sections including 
the surgical sites were removed and fixed in 10% neu-
tral buffered formalin solution for 10 days. All samples 
were decalcified in EDTA-HCl for 7 days and embedded 
in paraffin. Three micrometer thick coronal sections 
through the center of the augmented area were ob-
tained at 80um intervals, and stained with hematoxylin 
and eosin (H&E). The most central section from each 
block was selected for the histologic and histomorpho-
metric evaluation. After conventional microscopic ex-
amination, computer-assisted histomorphometric meas-
urements were done using an automated image analysis 
system (Image-Pro Plus®, Media Cybernetics, Silver 
Spring, MD, USA) coupled with a video camera on a 
light microscope (Olympus BX50, Olympus Optical Co., 
Tokyo, Japan). The sections were examined at ×10 
magnification. A digitizer was used to trace the defect 
outline versus new bone formation, and the percentage 
of bone fill was determined. The value of each meas-
urement was automatically calculated by the image 
Figure 1. Disc-shaped MBCP block implant used (3mm in height 
and 8mm in diameter) in this study. 
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analysis system. The following histomorphometric pa-
rameters were measured for each section (Fig. 2).
1) Augmented area (mm2) was measured as all tis-
sues within the boundaries of the MBCP block, 
including new bone, the residual biomaterials, 
fatty marrow and fibrovascular tissue/marrow.
2) New bone area (mm2) was determined by the 
newly formed bone area within the total aug-
mented area.
3) Bone density (%) was determined by the percent-
age of newly formed bone area within the total 
augmented area: Bone density (%) = (New bone 
area / Augmented area) ×100
5. Statistical Analysis 
Histomorphometric recordings from the samples 
were used to calculate group median and range. The 
Wilcoxon two sample test was used for statistical 
analysis of the difference between two groups. P-value 
＜0.05 was considered statistically significant. 
Results
1. Clinical observation
Wound healing was generally uneventful and similar 
for all groups. There were no macroscopic signs of 
infection. 
2. Histologic observation
At 2 weeks, new bone formation was observed in 
the bottom of the MBCP block (Fig. 3). Bone for-
mation was significantly enhanced at 8 weeks. The 
new bone appeared more lamellar at 8 weeks than that 
at 2 weeks. A large number of osteocytes, osteblasts, 
and osteoclasts were observed in the area of new bone 
formation. The incremental lines, fatty marrow and 
concentric ring of the Haversian system were also ob-
served in this area. The pattern of newly formed bone 
moved from outside to the inside of the defect (Fig. 4). 
There was no significantly different appearance by 
the membrane compared with rhBMP-2/MBCP block 
only. At 8 weeks, new bone formation was significant 
and more enhanced than at 2 weeks (Fig. 5, 6). In 
addition, an even bone formation pattern under mem-
brane was observed (Fig. 6-B). However, in the 
rhBMP-2/MBCP group, the bone formation pattern 
was irregular at the top of MBCP block (Fig. 4-B). 
The new bone formation pattern was similar in the 
central and base parts (bottom of defect) of the both 
groups (Fig. 4-C, D and Fig. 6-C, D).
Figure 2. Schematic drawing of calvarial osteotomy defect showing histomorphometirc analysis.
Original Bone
Defect Margin
MBCP Block
New Bone
Fatty Marrow + Fibrovascular Tissue/Marrow
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Figure 3. Representative photomicrograph of rhBMP-2/MBCP 
group at 2 weeks. New bone formation was observed in the bot-
tom of MBCP block and adjacent to the margins of the defect (▲
=defect margin; H&E stain; original magnification ×10).
Figure 5. Representative photomicrograph of rhBMP-2/MBCP 
/ePTFE group at 2 weeks. New bone formation was observed in 
the bottom of MBCP block and adjacent to the margins of the 
defect (▲=defect margin; H&E stain; original magnification ×10).
Figure 4. Representative photomicrograph of rhBMP-2/MBCP 
group at 8 weeks (B, C and D; boxed area in A). At 8 weeks, 
more bone formation was observed in the base area comparing 
with 2 weeks. A lot of new bone was observed in top of MBCP 
block. However, bone formation pattern was irregular (▲=defect 
margin; ✽=MBCP remnants; NB=new bone; H&E stain; original 
magnification: A ×10; B, C and D ×100).
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3. Histomorphometric analysis
Table 1, 2 and 3 show the results of histomorpho-
metric analysis. Total augmented area and new bone 
area were not significantly different between two 
groups at 2 and 8 weeks. In terms of new bone area 
and bone density, the ePTFE membrane generally
showed a slight beneficial effect on bone formation at 
2 weeks, although this was not statistically significant 
as shown in Table 2 and Table 3. Regarding the bone 
density, there were statistically significant differences 
between 2 weeks and 8 weeks results in both groups 
(P＜0.05). However, there were no significant differ-
ences between the two groups at 2 and 8 weeks of 
examination. 
Figure 6. Representative photomicrograph of rhBMP-2/MBCP/ePTFE 
group at 8 weeks (B, C and D; boxed area in A). In the top of MBCP 
block, a lot of new bone was observed and the appearance of the 
new bone was more lamellar than at 2 weeks and the pattern of 
bone formation beneath membrane was more even than in the 
rhBMP-2/MBCP group (▲=defect margin; ✽=MBCP remnants; 
NB=new bone; H&E stain; original magnification: A ×10; B, C and D 
×100).
Table 1. Total Augmented Area (Median & Range; mm2, n=7)
Group 2 weeks 8 weeks
rhBMP-2 / MBCP 13.45 7.21 19.69    10.7
rhBMP-2 / MBCP / ePTFE 18.57 7.31 17.93    12.64
Table 2. New Bone Area (Median & Range; mm2, n=7)
Group 2 weeks 8 weeks
rhBMP-2 / MBCP 1.43 0.53 4.52 3.86
rhBMP-2 / MBCP / ePTFE 3.03 3.84 4.88 7.85
Table 3. Bone Density (Median & Range; %, n=7)
Group 2 weeks 8 weeks
rhBMP-2 / MBCP 10.69     6.05 25.06 15.14*
rhBMP-2 / MBCP / ePTFE 14.27    14.75 26.35 40.72*
* Statistically significant difference when compared to 2 weeks (P＜0.05).
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Discussion
This study investigated the additive effect of ePTFE 
membrane on bone regeneration after the implantation 
of a rhBMP-2/MBCP block in a critical-sized rat cal-
varial defect model. The defects were implanted with 
either a rhBMP-2/BMCP block or a rhBMP-2/MBCP 
block/ePTFE membrane. The level of healing was 
evaluated histologically and histomorphometrically af-
ter a 2- and 8-week healing period.
In our previous study24), we demonstrated the bone 
regenerative effect of rhBMP-2 delivered with a MBCP 
block in a rat calvarial defect model. The rationale 
behind the study was to utilize the favorable bone 
healing capacity of the MBCP block, which has an os-
teoconductive effect, and the volumetric predictability 
over the healing time because of the low resorption 
rate and the resistance of the block type against soft 
tissue compression. The favorable osteoconductive ef-
fect of the MBCP in bone healing has been well docu-
mented15-17). It was suggested that the higher local 
calcium and phosphate concentrations in MBCP might 
have a stimulatory effect on bone formation. In addi-
tion to the osteoconductive effect of MBCP, there are 
many reports showing the osteoinductive effect of 
MBCP when implanted in ectopic sites in various spe-
cies25-27).
It was expected that the use of a MBCP block as a 
rhBMP-2 carrier would result in predictable new bone 
formation in terms of the volume and shape. In a 
clinical point of view, a carrier for the delivery of 
BMPs should serve as a scaffold for bone forming cells 
while providing a space for bone formation to occur. 
In addition, the space should be maintained for a rel-
atively long period in order to allow sufficient matu-
ration of the newly formed bone. In terms of clinical 
bone tissue engineering, provision of the volume and 
shape of the bone tissue is a key factor for treatment 
success. In the previous study investigating the effect 
of rhBMP-2/MBCP block on bone formation in rat 
calvarial defects after 2 and 8 weeks healing period, 
the new bone area in the rhBMP-2/MBCP block (2 
weeks;3.0±0.9mm2, 8 weeks;5.5±2.2mm2) was sig-
nificantly larger than that in the MBCP block alone (2 
weeks;1.0±0.6mm2, 8 weeks;3.0±0.9mm2). Therefore, 
it was suggested that the MBCP block is an effective 
carrier system of rhBMP-2 with the volumetric stabil-
ity24). Therefore, in this experiment, a MBCP block 
only group without rhBMP-2 was not included because 
the aim was to confirm the regenerative effects of the 
rhBMP-2/MBCP block and to determine whether or not 
the placement of an ePTFE barrier membrane would 
have a synergistic effect. 
In this study, there was significant better enhance-
ment of bone formation in the defects of both the 
rhBMP-2/MBCP group and rhBMP-2/MBCP/ePTFE 
group at 8 weeks than at 2 weeks. However, although 
rhBMP-2/MBCP block induced new bone formation in 
the augmented defect, the placed ePTFE barrier mem-
branes had no positive effect on bone regeneration. 
There has been some controversy regarding the ad-
ditional benefits of the membrane on bone re-
generation by rhBMP19-23). An earlier study demon-
strated that the initiation and rate of bone healing 
beneath the osteopromotive membranes can be en-
hanced significantly by the implantation of rhBMP-2. 
However, membrane placement per se significantly 
hampered the osteoinductive capacity of the BMP21). 
On the other hand, several studies22,23) have reported 
the synergistic effect of a combination of rhBMP-2 
and osteopromotive membranes, which led to rapid, 
complete graft integration and size maintenance with-
out extensive regenerative bone resorption and graft 
size reduction. Moreover, rhBMP-2 appeared to accel-
erate the remodeling of the graft in the absence of a 
membrane. However, all these studies used easily de-
gradable materials, such as ACS and poly(D,L-lac-
tide-co-glycolide) (PLA/PGA) as rhBMP-2 carrier. In 
contrast, the MBCP block has a volumetric character-
istic that maintains the shape during bone formation 
by rhBMP-2. Therefore, when used as a carrier for 
rhBMP-2, the MBCP block itself can have a similar 
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function to a membrane. This is confirmed in a pre-
vious study, which reported a decrease in the bio-
logical resorption of the MBCP block at 1 month after 
implantation in dogs as a result of the protective ef-
fect of the newly formed lamellar bone on the surface 
and in the core of the block28). In our experiment, this 
effect of the MBCP block was confirmed by the fact 
that the ePTFE membrane generally showed a slight 
beneficial effect on bone formation at 2 weeks after 
rhBMP-2/MBCP block implantation than at 8 weeks, 
although this was not statistically significant (Table 2 
and Table 3). However, a synergistic effect of ePTFE 
might not be observed at 8 weeks because new bone 
was already induced by rhBMP-2 on the surface of the 
MBCP block in the initial healing stage, which might 
inhibit the in-growth of soft tissue into the defects 
(Fig. 3 and Fig. 4). 
The slight beneficial effect of the ePTFE membrane 
observed in the initial healing stage (2 weeks) ap-
peared to be partly because the membrane created an 
environment that prevents the invasion of competing 
cells from the overlying soft tissue and partly because 
the membrane can have the advantage of keeping the 
rhBMP-2 implant in place. However, although the cell 
occlusivity of the membrane has been mentioned as a 
critical determinant for guided tissue regeneration29), 
the real importance of cell occlusion for optimal re-
generation is unclear30). Recent studies have suggested 
that tissue occlusion does not appear to be a critical 
determinant for GTR but may be a requirement for 
optimal GTR31,32). Therefore, as shown in our results, 
the tissue occlusion of the ePTFE membrane might 
have only an accessory effect when the space for bone 
regeneration is obtained using other materials, such 
as a MBCP block. However, if an absorbable and 
non-spacemaking material such as ACS is used as a 
rhBMP carrier, it would be advantageous to apply a 
membrane to obtain volume maintenance because bar-
rier-membrane placement may be useful for graft re-
tention as well as for predetermining the final shape 
of the regenerative site.
In conclusion, these results showed that the use of 
a rhBMP-2/MBCP block, regardless of combined use of 
an ePTFE membrane, can achieve bone augmentation 
with significant bone formation. This suggests that 
the MBCP block is a suitable carrier of rhBMP-2 and 
might be effective in maintaining the space needed for 
guided bone regeneration. In addition, these findings 
showed that the ePTFE membrane has no synergistic 
effect on bone formation when a MBCP block is used 
as a carrier for rhBMP-2.
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